White Paper

Device Development For Pharmaceutical And Biologic Combo Products

Source: Phillips-Medisize

Combination products are therapeutics combining two or more products that are regulated and sold as a single unit. When developing a combination product, there are many aspects that need to be considered such as the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, and device manufacturing variation.

Development Strategy and Scaling
Engaging in an efficient combo product development process begins with understanding your regulatory and clinical strategies. Creating these strategies, as early as possible, will help ensure the device development is well aligned with the pharmaceutical (drug) or biologic development and applicable regulatory requirements. In addition, having these strategies in place will reduce time to market.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online